liabilities - 0% 17,826 0% 20,909 0% 21,613 0% Employee benefit obligations 149,358 2% 163,856 2% 167,253 2% 135,134 3% Other non-current liabilities 153,539 2% 130,432 2% 105,061 1% 94,970 2% Total non-current
by THB 7.5 million or 21.4%. It was increased from employee benefit expenses which the Group has increased in team of developing the new software. Net Profit The Group reported total net profit for the
Administrative expenses, impairment finance costs and share of loss from associates 57.53 777.43 37.52 78.22 Doubtful Account 86.50 1,168.92 - - Loss on impairment of goodwill 51.20 691.89 - - Management benefit
. - Other liabilities consisted of bank overdrafts, deferred tax liabilities, employee benefit obligation.
benefit expenses 14.16 124.10 17.84 33.51 Financial cost 0.14 1.23 0.34 0.64 Share of losses in associates 64.23 562.93 2.91 5.46 Profit (Loss) before tax (274.97) (2,409.90) (94.15) (176.84) Tax
, because the Company have paid Baht 26.95 million for the loan and received more loan of Baht 19 million. - Other liabilities consisted of bank overdrafts, deferred tax liabilities, employee benefit
appropriate by Dhipaya Bodin as a joint venture. It will benefit potential shareholders in the medical device and distribution business. The current production and distribution line is Blood Line with a
financial assistance is reasonable and such assistance will directly benefit the business to the company. Therefore, the company has approved to provide financial assistance to Thai Japan Laboratories Co
will benefit to the financial position of the company and the shareholders in the long term. 11. Opinions from the Audit Committee and/or the Directors that are different from the Opinions from the Board
contribute the Company‘s further benefit. Opinions by the Audit Committee and/or Director significantly different from those by the Board of Directors : -None- Please be informed accordingly Yours sincerely